APLT Biotech NASDAQ Penny LONGApplied Therapeutics is an uptrending biotechnology company that has earnings
in prior quarters and is heading into another earnings report about may 11th.
The run up in price cction is largely on the proposition of future growth much
like TSLA back in the day.
On the chart besides the obvious uptrend, the volume indicator shows a dramatic
volume surge compared with the running 50 day average while the MACD shows
the lines above the histogram and running upward and parallel.
The ideal entry would be a pullback as the price is now quite extended however
I do not believe that will occur until at least after earnings. I believe
this strong runner will continue until earnings unabated.
As a penny stock many shares can be taken and then the position can be closed
in partials along the way thus taking profits and decreasing the risk in steps.
The same applies to the call options.
